Effect of taxifolin on clozapine-induced experimental oxidative and inflammatory heart damage in rats

IF 0.5 4区 医学 Q4 PSYCHIATRY
Emine Fusun Akyuz Cim , Halis Suleyman
{"title":"Effect of taxifolin on clozapine-induced experimental oxidative and inflammatory heart damage in rats","authors":"Emine Fusun Akyuz Cim ,&nbsp;Halis Suleyman","doi":"10.1016/j.amp.2023.08.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><div><span>Clozapine is an atypical antipsychotic (AAP) drug used in treatment-resistant schizophrenia patients. The adverse effects of clozapine<span> on the heart may result in death and require drug discontinuation. Inflammatory mechanisms are thought to be responsible for the negative effect of clozapine on the heart. This suggests that using an agent with anti-inflammatory and antioxidant properties, which may be specific to clozapine-induced heart damage, may prevent possible damage. The aim of our study is to evaluate the effect of taxifolin (</span></span><em>3</em>,<em>5</em>,<em>7</em>,<em>3</em>’,<em>4’-pentahydroxy</em> flavanone), an agent with known antioxidant and anti-inflammatory effects, on myocardial damage caused by clozapine with biochemical and histopathological data.</div></div><div><h3>Material and method</h3><div>The rats were divided into three equal groups: healthy control group (HC), clozapine-treated group (CLN), and taxifolin<!--> <!-->+<!--> <!-->clozapine-treated group (TCL). To perform this experiment, taxifolin was administered to TCL (n-6) rats at a dose of 50<!--> <!-->mg/kg orally by gavage into the stomach. In the HC (n-6) and CLN (n-6) groups, the same volume of distilled water was administered orally as a solvent. One hour after the administration of taxifolin and distilled water, clozapine was administered orally at a dose of 20<!--> <!-->mg/kg to the TCL and CLN groups once a day for 28 days. At the end of the period, troponin I (TP I) and creatine kinase MB (CK-MB) levels were measured in the venous blood of each group. Malondialdehyde (MDA), total glutathione (tGSH), TNF-α, NF-<figure><img></figure>B, and IL-1β levels were measured in samples taken from heart tissues. Additionally, heart tissues were evaluated histopathologically.</div></div><div><h3>Results</h3><div>Troponin I, CK-MB, MDA, TNF-α, NF-<figure><img></figure>B, and IL-1β levels, myocardial degeneration, myofiber irregularity, and congestion scores were significantly higher and tGSH levels were lower in the clozapine group than in the healthy control and taxifolin<!--> <!-->+<!--> <!-->clozapine groups (<em>P</em> <!-->&lt;<!--> <!-->0.05). Compared with the healthy control group, troponin I, tGSH, and NF-KB levels were similar (<em>P</em> <!-->&gt;<!--> <!-->0.05), CK-MB, MDA, TNF-α, and IL-1β levels were higher in the taxifolin<!--> <!-->+<!--> <!-->clozapine group, while they were significantly lower than the clozapine group (<em>P</em> <!-->&lt;<!--> <!-->0.05). Histopathologically evaluated myocardial degeneration, myofiber irregularity, and congestion score were significantly lower in the taxifolin<!--> <!-->+<!--> <!-->clozapine group than in the clozapine group. In the clozapine group (CLN group), myofibers were found to have irregular patterns and were observed as irregular. In the taxifolin<!--> <!-->+<!--> <!-->clozapine group (TLC group), myofibrils generally showed a regular morphology.</div></div><div><h3>Conclusion</h3><div>We found that taxifolin can ameliorate damage to myocardial tissue by regulating oxidant-antioxidant and proinflammatory cytokine levels. The data of our study suggest that taxifolin may be useful in the treatment of clozapine-induced myocardial injury.</div></div>","PeriodicalId":7992,"journal":{"name":"Annales medico-psychologiques","volume":"182 9","pages":"Pages 823-829"},"PeriodicalIF":0.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales medico-psychologiques","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0003448723002317","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim

Clozapine is an atypical antipsychotic (AAP) drug used in treatment-resistant schizophrenia patients. The adverse effects of clozapine on the heart may result in death and require drug discontinuation. Inflammatory mechanisms are thought to be responsible for the negative effect of clozapine on the heart. This suggests that using an agent with anti-inflammatory and antioxidant properties, which may be specific to clozapine-induced heart damage, may prevent possible damage. The aim of our study is to evaluate the effect of taxifolin (3,5,7,3’,4’-pentahydroxy flavanone), an agent with known antioxidant and anti-inflammatory effects, on myocardial damage caused by clozapine with biochemical and histopathological data.

Material and method

The rats were divided into three equal groups: healthy control group (HC), clozapine-treated group (CLN), and taxifolin + clozapine-treated group (TCL). To perform this experiment, taxifolin was administered to TCL (n-6) rats at a dose of 50 mg/kg orally by gavage into the stomach. In the HC (n-6) and CLN (n-6) groups, the same volume of distilled water was administered orally as a solvent. One hour after the administration of taxifolin and distilled water, clozapine was administered orally at a dose of 20 mg/kg to the TCL and CLN groups once a day for 28 days. At the end of the period, troponin I (TP I) and creatine kinase MB (CK-MB) levels were measured in the venous blood of each group. Malondialdehyde (MDA), total glutathione (tGSH), TNF-α, NF-
B, and IL-1β levels were measured in samples taken from heart tissues. Additionally, heart tissues were evaluated histopathologically.

Results

Troponin I, CK-MB, MDA, TNF-α, NF-
B, and IL-1β levels, myocardial degeneration, myofiber irregularity, and congestion scores were significantly higher and tGSH levels were lower in the clozapine group than in the healthy control and taxifolin + clozapine groups (P < 0.05). Compared with the healthy control group, troponin I, tGSH, and NF-KB levels were similar (P > 0.05), CK-MB, MDA, TNF-α, and IL-1β levels were higher in the taxifolin + clozapine group, while they were significantly lower than the clozapine group (P < 0.05). Histopathologically evaluated myocardial degeneration, myofiber irregularity, and congestion score were significantly lower in the taxifolin + clozapine group than in the clozapine group. In the clozapine group (CLN group), myofibers were found to have irregular patterns and were observed as irregular. In the taxifolin + clozapine group (TLC group), myofibrils generally showed a regular morphology.

Conclusion

We found that taxifolin can ameliorate damage to myocardial tissue by regulating oxidant-antioxidant and proinflammatory cytokine levels. The data of our study suggest that taxifolin may be useful in the treatment of clozapine-induced myocardial injury.
紫杉叶素对氯氮平诱发的大鼠实验性氧化性和炎症性心脏损伤的影响
目的氯氮平是一种非典型抗精神病药(AAP),用于治疗耐药性精神分裂症患者。氯氮平对心脏的不良影响可能导致死亡,因此需要停药。炎症机制被认为是氯氮平对心脏产生不良影响的原因。这表明,使用一种具有抗炎和抗氧化特性的药剂(可能专门针对氯氮平引起的心脏损伤)可以预防可能的损伤。我们的研究旨在通过生化和组织病理学数据评估一种已知具有抗氧化和抗炎作用的药物 Taxifolin(3,5,7,3',4'-五羟基黄烷酮)对氯氮平引起的心肌损伤的影响。在实验过程中,TCL(n-6)大鼠以 50 毫克/千克的剂量经胃灌胃服用紫杉叶素。在 HC 组(n-6)和 CLN 组(n-6)中,口服相同体积的蒸馏水作为溶剂。在服用紫杉叶素和蒸馏水一小时后,给 TCL 组和 CLN 组口服氯氮平,剂量为 20 毫克/千克,每天一次,连续 28 天。期末,测量各组静脉血中肌钙蛋白 I(TP I)和肌酸激酶 MB(CK-MB)的水平。测量心脏组织样本中丙二醛(MDA)、总谷胱甘肽(tGSH)、TNF-α、NF-B 和 IL-1β 的水平。结果 氯氮平组的肌钙蛋白 I、CK-MB、MDA、TNF-α、NF-B 和 IL-1β 水平、心肌变性、肌纤维不规则和充血评分显著高于健康对照组和紫杉叶素 + 氯氮平组,而 tGSH 水平则低于健康对照组和紫杉叶素 + 氯氮平组(P < 0.05)。与健康对照组相比,肌钙蛋白 I、tGSH 和 NF-KB 水平相似(P >;0.05),CK-MB、MDA、TNF-α 和 IL-1β 水平在 Taxifolin + 氯氮平组较高,而在氯氮平组则明显较低(P <;0.05)。组织病理学评估的心肌变性、肌纤维不规则和充血评分在紫杉叶素+氯氮平组明显低于氯氮平组。氯氮平组(CLN 组)的心肌纤维形态不规则,被观察为不规则。结论我们发现,紫杉叶素可通过调节氧化抗氧化剂和促炎细胞因子水平来改善心肌组织的损伤。我们的研究数据表明,紫杉叶素可用于治疗氯氮平诱发的心肌损伤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annales medico-psychologiques
Annales medico-psychologiques 医学-精神病学
CiteScore
1.30
自引率
33.30%
发文量
196
审稿时长
4-8 weeks
期刊介绍: The Annales Médico-Psychologiques is a peer-reviewed medical journal covering the field of psychiatry. Articles are published in French or in English. The journal was established in 1843 and is published by Elsevier on behalf of the Société Médico-Psychologique. The journal publishes 10 times a year original articles covering biological, genetic, psychological, forensic and cultural issues relevant to the diagnosis and treatment of mental illness, as well as peer reviewed articles that have been presented and discussed during meetings of the Société Médico-Psychologique.To report on the major currents of thought of contemporary psychiatry, and to publish clinical and biological research of international standard, these are the aims of the Annales Médico-Psychologiques.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信